Arria and Glemser leverage AI to transform clinical trial research
June 18, 2020 |
Are you leveraging technology the right way to bring scale, efficiency, and compliance to your clinical trials?
The Arria and Glemser partnership presents a new way to use AI to make strategic decisions around your clinical trials while doing more with less, maintaining current workflows, and becoming faster and more efficient.
Recently our teams came together in a virtual event to discuss clinical research trends and the biggest challenges facing the Life Science industry. In addition, we speak about how using the right technology can enable users to:
• Accelerate trial outcomes • Automate personalize narrative to meet regulatory standards • Scale to meet global demand and save lives